» Articles » PMID: 33407765

HOMER3 Facilitates Growth Factor-mediated β-Catenin Tyrosine Phosphorylation and Activation to Promote Metastasis in Triple Negative Breast Cancer

Overview
Journal J Hematol Oncol
Publisher Biomed Central
Specialties Hematology
Oncology
Date 2021 Jan 7
PMID 33407765
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: HOMER family scaffolding proteins (HOMER1-3) play critical roles in the development and progression of human disease by regulating the assembly of signal transduction complexes in response to extrinsic stimuli. However, the role of HOMER protein in breast cancer remains unclear.

Methods: HOMER3 expression was examined by immunohistochemistry in breast cancer patient specimens, and its significance in prognosis was assessed by Kaplan-Meier survival analysis. The effects of HOMER3 in growth factor-induced β-Catenin activation were analyzed by assays such as TOP/FOP flash reporter, tyrosine phosphorylation assay and reciprocal immunoprecipitation (IP) assay. Role of HOMER3 in breast cancer metastasis was determined by cell function assays and mice tumor models.

Results: Herein, we find that, among the three HOMER proteins, HOMER3 is selectively overexpressed in the most aggressive triple negative breast cancer (TNBC) subtype, and significantly correlates with earlier tumor metastasis and shorter patient survival. Mechanismly, HOMER3 interacts with both c-Src and β-Catenin, thus providing a scaffolding platform to facilitate c-Src-induced β-Catenin tyrosine phosphorylation under growth factor stimulation. HOMER3 promotes β-Catenin nuclear translocation and activation, and this axis is clinically relevant. HOMER3 promotes and is essential for EGF-induced aggressiveness and metastasis of TNBC cells both in vitro and in vivo.

Conclusion: These findings identify a novel role of HOMER3 in the transduction of growth factor-mediated β-Catenin activation and suggest that HOMER3 might be a targetable vulnerability of TNBC.

Citing Articles

Upregulation of ENAH by a PI3K/AKT/β-catenin cascade promotes oral cancer cell migration and growth via an ITGB5/Src axis.

Chan X, Chang K, Yang C, Liu C, Hung C, Huang C Cell Mol Biol Lett. 2024; 29(1):136.

PMID: 39511483 PMC: 11545229. DOI: 10.1186/s11658-024-00651-0.


Camptothecin multifunctional nanoparticles effectively achieve a balance between the efficacy of breast cancer treatment and the preservation of intestinal homeostasis.

Liu Q, Yang Y, Pan M, Shi K, Mo D, Li Y Bioact Mater. 2024; 41:413-426.

PMID: 39184827 PMC: 11342206. DOI: 10.1016/j.bioactmat.2024.07.032.


Identification of homer protein homolog 3 as a prognostic marker of colon adenocarcinoma.

Luo M, Zhao C, Zhao Y, Wang Y, Li P Heliyon. 2024; 10(13):e33344.

PMID: 39035486 PMC: 11259827. DOI: 10.1016/j.heliyon.2024.e33344.


HOMER3 promotes non-small cell lung cancer growth and metastasis primarily through GABPB1-mediated mitochondrial metabolism.

Sun T, Song C, Zhao G, Feng S, Wei J, Zhang L Cell Death Dis. 2023; 14(12):814.

PMID: 38081871 PMC: 10713516. DOI: 10.1038/s41419-023-06335-5.


Organotypic 3D Cell-Architecture Impacts the Expression Pattern of miRNAs-mRNAs Network in Breast Cancer SKBR3 Cells.

Gastelum-Lopez M, Aguilar-Medina M, Garcia Mata C, Lopez-Gutierrez J, Romero-Quintana G, Bermudez M Noncoding RNA. 2023; 9(6).

PMID: 37987362 PMC: 10661268. DOI: 10.3390/ncrna9060066.


References
1.
Zhang M, Ferrigno O, Wang Z, Ohnishi M, Prunier C, Levy L . TGIF governs a feed-forward network that empowers Wnt signaling to drive mammary tumorigenesis. Cancer Cell. 2015; 27(4):547-60. PMC: 4398914. DOI: 10.1016/j.ccell.2015.03.002. View

2.
Zeke A, Lukacs M, Lim W, Remenyi A . Scaffolds: interaction platforms for cellular signalling circuits. Trends Cell Biol. 2009; 19(8):364-74. PMC: 3073007. DOI: 10.1016/j.tcb.2009.05.007. View

3.
Ismail-Khan R, Bui M . A review of triple-negative breast cancer. Cancer Control. 2010; 17(3):173-6. DOI: 10.1177/107327481001700305. View

4.
Karagoz K, Lehman H, Stairs D, Sinha R, Arga K . Proteomic and Metabolic Signatures of Esophageal Squamous Cell Carcinoma. Curr Cancer Drug Targets. 2016; . View

5.
Yang W, Xia Y, Ji H, Zheng Y, Liang J, Huang W . Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation. Nature. 2011; 480(7375):118-22. PMC: 3235705. DOI: 10.1038/nature10598. View